Skip to main content

Refine your search

Timo Myöhänen.

Timo Myöhänen appointed as Professor of Pharmacology and Drug Development at UEF

In the future, a growing number of neurodegenerative diseases could ideally be treated with the same drug, says Timo Myöhänen, the University of Eastern Finland’s newly appointed Professor of Pharmacology and Drug Development. The target of such a drug could be, for example, the PREP enzyme, which affects several factors underlying cell death in the brain.

Drug development should focus on targets that have the potential to affect several disease mechanisms at the same time.

Timo Myöhänen

Professor of Pharmacology and Drug Development